Pfizer Inc. (PFE)

26,32 +0,06 (+0,23%) Al cierre: 04:00PM EDT

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sector(es): Healthcare
Sector: Drug Manufacturers - General
Empleados a tiempo completo: 88.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Albert Bourla D.V.M., Ph.D.	Chairman of the Board & CEO	4,05M	N/A	1962
Mr. David M. Denton	Chief Financial Officer & Executive VP	1,75M	N/A	1965
Dr. Mikael Dolsten M.D., Ph.D.	Chief Scientific Officer and President of Research & Development	2,41M	N/A	1958
Mr. Douglas M. Lankler	Executive VP & General Counsel	1,76M	N/A	1966
Mr. Aamir Malik	Executive VP & Chief U.S. Commercial Officer	1,89M	N/A	1976
Ms. Jennifer B. Damico	Senior VP, Controller & Principal Accounting Officer	N/A	N/A	1968
Ms. Lidia L. Fonseca	Executive VP and Chief Digital & Technology Officer	N/A	N/A	1969
Ms. Francesca M. DeMartino	Chief Investor Relations Officer	N/A	N/A	N/A
Mr. Rady A. Johnson	Executive VP and Chief Compliance, Quality & Risk Officer	N/A	N/A	1962
Mr. Andreas J. Panayiotou	Global Chief Marketing Officer	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Gobierno corporativo

El ISS Governance QualityScore de Pfizer Inc., a día 1 de abril de 2024, es 5. Las puntuaciones base son Auditoría: 10; Tablero: 6; Derechos de los accionistas: 1; Compensación: 3.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.